LNMG.US Linike Medical Group Ltd
- Market cap
- USD 4.17M
- P/E
- -
- P/B
- -
- ROE
- 2.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.
Is LNMG.US undervalued?
Graham numberThe Graham number of Linike Medical Group Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Linike Medical Group Ltd fundamental analysis
No fundamental analysis for Linike Medical Group Ltd yet.
Linike Medical Group Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Linike Medical Group Ltd
Linike Medical Group Ltd. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd. in August 2021. Linike Medical Group Ltd. is based in Calgary, Canada.
Full company profileLinike Medical Group Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Linike Medical Group Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 15.7K | 69.3K | - | - | - | - | - | 8.95M | 13.0M | 10.7M | 10.7M |
| Gross Profit | 15.7K | 42.3K | -593.00 | - | - | - | - | 8.89M | 13.0M | 10.5M | - |
| Operating Income | -42.2K | -88.0K | -215K | -1.08K | -88.6K | -29.9K | -66.0K | 991K | -245K | 3.09M | 1.03M |
| EBITDA | -39.9K | -85.8K | -215K | -1.08K | -88.6K | -29.9K | -66.0K | 1.06M | -190K | 3.22M | 1.28M |
| Net Income | -42.1K | -88.4K | -428K | -1.08K | -88.6K | -29.9K | -66.0K | 991K | -245K | 3.09M | 1.03M |
| EPS | -0.36 | 0.00 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 103K | 33.0K | 5.59K | - | 3.50K | 3.75K | 1.41K | 54.7M | 55.6M | 57.7M | 56.2M |
| Total Liabilities | 3.84K | 23.2K | 486K | - | 21.8K | 51.9K | 76.7K | 19.6M | 20.7M | 19.7M | 17.4M |
| Shareholders' Equity | 98.7K | 9.75K | -481K | - | -18.3K | -48.1K | -75.3K | 35.1M | 34.9M | 38.0M | 38.8M |
| Cash & Short-term Investments | 98.5K | 27.9K | 2.59K | - | - | 1.14K | 1.41K | 789K | 688K | 492K | 109K |
| Total Debt | - | - | - | - | 20.7K | 44.2K | 63.3K | 17.1M | 18.2M | 17.4M | 16.0M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -47.8K | -82.0K | -28.5K | - | -20.8K | -22.0K | -19.1K | -2.26M | -767K | -15.3K | -605K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 58.8K | 228K | 247K | 406K |
| Free Cash Flow | -47.8K | -82.0K | -28.5K | - | -20.8K | -22.0K | -19.1K | -2.32M | -995K | -263K | -859K |
| Ratios | |||||||||||
| ROE | -42.7% | -906.6% | - | - | - | - | - | 2.8% | -0.7% | 8.1% | 2.6% |
| ROA | -41.1% | -267.8% | -7,659.2% | - | -2,530.5% | -797.1% | -4,669.4% | 1.8% | -0.4% | 5.4% | 1.8% |
| Net Profit Margin | -268.8% | -127.5% | - | - | - | - | - | 11.1% | -1.9% | 28.9% | 9.6% |
| Debt to Equity | - | - | - | - | - | - | - | 0.49x | 0.52x | 0.46x | 0.41x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Linike Medical Group Ltd dividends
Linike Medical Group Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1:50 on Jun 8, 2020.
Who owns Linike Medical Group Ltd
Ownership data of Linike Medical Group Ltd is not available yet.
Linike Medical Group Ltd company profile
- Company name
- Linike Medical Group Ltd
- Ticker
- LNMG.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Capital Markets
- Fiscal year end
- October
- Address
- 833?1st Avenue NW, Calgary, AB, Canada, T2N 0A4
- Website
- dinoenergycorporation.com
About Linike Medical Group Ltd
Linike Medical Group Ltd. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd. in August 2021. Linike Medical Group Ltd. is based in Calgary, Canada.
Linike Medical Group Ltd management
1- Mr. Eric David LawsonDirector, CEO, CFO & President · born 1946